Revenue for H1 2026 was €7.4 million, with strong growth in high value-added lipid sales and the first order for the natural blue dye Galdieria Blue™. The outlook anticipates accelerated revenue growth in H2 2026, targeting €20 million annual revenue.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.